Cargando…
Intravenous paracetamol in comparison with ibuprofen for the treatment of patent ductus arteriosus in preterm infants: a randomized controlled trial
Our aim was to assess the efficacy and safety of intravenous (i.v.) paracetamol vs. i.v. ibuprofen for the treatment of hemodynamically significant patent ductus arteriosus (hsPDA) in preterm infants. This is a multicenter randomized controlled study. Infants with a gestational age of 25(+0)–31(+6) ...
Autores principales: | Dani, Carlo, Lista, Gianluca, Bianchi, Silvia, Mosca, Fabio, Schena, Federico, Ramenghi, Luca, Zecca, Enrico, Vento, Giovanni, Poggi, Chiara, Leonardi, Valentina, Minghetti, Diego, Rosignoli, Maria Teresa, Calisti, Fabrizio, Comandini, Alessandro, Cattaneo, Agnese, Lipone, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886841/ https://www.ncbi.nlm.nih.gov/pubmed/32888085 http://dx.doi.org/10.1007/s00431-020-03780-8 |
Ejemplares similares
-
Efficacy and safety of intravenous paracetamol in comparison to ibuprofen for the treatment of patent ductus arteriosus in preterm infants: study protocol for a randomized control trial
por: Dani, Carlo, et al.
Publicado: (2016) -
Oral paracetamol versus oral ibuprofen for treatment of patent ductus arteriosus
por: Al-lawama, Manar, et al.
Publicado: (2017) -
Paracetamol in Patent Ductus Arteriosus Treatment: Efficacious and Safe?
por: Bardanzellu, Flaminia, et al.
Publicado: (2017) -
Comparison of Oral Paracetamol versus Ibuprofen in Premature Infants with Patent Ductus Arteriosus: A Randomized Controlled Trial
por: Dang, Dan, et al.
Publicado: (2013) -
Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol
por: García-Robles, Ana, et al.
Publicado: (2020)